DALLAS, May 7, 2015 /PRNewswire/ --
According to a new market research report "Cell Counting Market by Product [(Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer) Consumables (Reagent, Assay Kits, Microplate)], End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2020", published by MarketsandMarkets, the global Cell Counting Market is expected to reach $8.6 Billion by the end of 2020 and is poised to grow at a CAGR of 6.5% to 7.0% during the forecast period 2015 to 2020.
Browse 130 market data Tables and 25 Figures spread through 150 Pages and in-depth TOC on "Cell Counting Market"
Early buyers will receive 10% customization on this report.
The Cell Counting Market witnessed healthy growth during the last decade due to the growing stem cell research and rising incidences of cancer and AIDS, globally. However, high prices of advanced cell counting systems and reluctance among researchers to use advanced cell counting techniques are inhibiting the growth of this market to a certain extent.
In this report, the Cell Counting Market is segmented on the basis of products, end users, and regions. On the basis of products, the market is categorized into instruments and consumables. The instruments market is further divided into four major segments, namely, spectrophotometers, flow cytometers, hematology analyzer, and cell counters. The spectrophotometers segment is bifurcated into single-mode readers and multi-mode readers; while the cell counters segment is bifurcated into automated cell counters; and hemocytometers and manual cell counters. The consumables segment is subdivided into reagents, assay kits, microplates, accessories, and other consumables. Furthermore, on the basis of end users, the Cell Counting Market is categorized into hospitals and diagnostic laboratories, research institutions, pharmaceutical and biotechnology companies, and other end users.
Inquiry before Buying:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=157450728
In 2014, the spectrophotometers segment accounted for the largest share of the market. The introduction of enhanced data visualization and analysis software and growing out-of-pocket healthcare spending are boosting the growth of the spectrophotometers market.
On the basis of regions, North America accounted for the largest share of this market in 2014, followed by Europe, Asia-Pacific, and RoW. However, the Asia-Pacific region is the fastest-growing market for cell counting products primarily due to the rising aging population, increasing research collaborations, and increasing R&D and healthcare expenditure in this region. In addition, large-scale improvements in the healthcare infrastructure of countries such as China, Taiwan, and India are further driving the growth of this market.
Major players in the global Cell Counting Market include Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).
Browse Related Reports:
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain@http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets